NASDAQ:STAA - STAAR Surgical Stock Price, Price Target & More

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) released its quarterly earnings data on Wednesday, May, 2nd. The medical instruments supplier reported $0.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.04) by $0.08. The medical instruments supplier earned $27.09 million during the quarter, compared to analysts' expectations of $23 million. STAAR Surgical had a return on equity of 6.80% and a net margin of 0.66%. During the same period in the prior year, the firm posted ($0.05) EPS. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for STAAR Surgical.

4 equities research analysts have issued 1-year target prices for STAAR Surgical's shares. Their predictions range from $21.00 to $23.00. On average, they anticipate STAAR Surgical's share price to reach $21.6667 in the next twelve months. View Analyst Ratings for STAAR Surgical.

STAAR Surgical saw a decline in short interest in the month of May. As of May 15th, there was short interest totalling 494,547 shares, a decline of 49.1% from the April 30th total of 971,594 shares. Based on an average daily volume of 872,862 shares, the short-interest ratio is presently 0.6 days. Currently, 1.2% of the shares of the stock are short sold.

Some companies that are related to STAAR Surgical include Medidata Solutions (MDSO), Taro Pharmaceutical Industries (TARO), ELEKTA AB/ADR (EKTAY), Haemonetics (HAE), Premier (PINC), Hikma Pharmaceuticals (HKMPF), Sartorius (SARTF), HYPERA S A/S (HYPMY), Carl Zeiss Meditec (AFX), Mediclinic International (MDC), Orion (ORINY), HUTCHISON CHINA/S (HCM), Madrigal Pharmaceuticals (MDGL), Neogen (NEOG) and MEDNAX (MD).

Press coverage about STAA stock has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. STAAR Surgical earned a media sentiment score of 0.09 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 46.23 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

STAAR Surgical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Palo Alto Investors LP (8.45%), BlackRock Inc. (6.53%), Baillie Gifford & Co. (2.58%), Cortina Asset Management LLC (0.95%), Millennium Management LLC (0.79%) and Principal Financial Group Inc. (0.50%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Caren L Mason, Deborah J Andrews, Hans-Martin Blickensdoerfer, Keith Holliday and Samuel J Gesten. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cortina Asset Management LLC, Lincoln National Corp, A.R.T. Advisors LLC, Principal Financial Group Inc., Principal Financial Group Inc., Barclays PLC and Public Employees Retirement Association of Colorado. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday and Samuel J Gesten. View Insider Buying and Selling for STAAR Surgical.

STAA stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., King Luther Capital Management Corp, Next Century Growth Investors LLC, BlackRock Inc., Millrace Asset Group Inc., Palo Alto Investors LP, Element Capital Management LLC and GSA Capital Partners LLP. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $29.40.

STAAR Surgical has a market capitalization of $1.22 billion and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]